S. 4338
Referred to CommitteeIncreasing Transparency in Generic Drug Applications Act
Introduced 5/26/2022•117th Congress•Senate
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
5/26/2022 • Senate
Summary
Increasing Transparency in Generic Drug Applications Act
This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
Introduced in Senate • 5/26/2022
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationPrescription drugs
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
1
Democrats
1
Republicans
0
Independents
Sponsor
S[
Cosponsors (1)
S[
Bill Journey
Originated in the Senate
Introduced
May 26, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in Senate5/26/2022